Table 2 Relationship between CDKL3 expression and tumor characteristics in patients with prostate cancer.

From: Inhibition of CDKL3 downregulates STAT1 thus suppressing prostate cancer development

Features

No. of patients

CDKL3 expression

P value

low

high

All patients

156

83

73

 

Age (years)

   

0.542

 ≤69

81

45

36

 

 >69

75

38

37

 

Gleason Score

   

0.033

 <8

60

37

23

 

 ≥8

89

39

50

 

Grade

   

0.077

 1

12

12

0

 

 2

38

17

21

 

 3

99

47

52

 

Tumor infiltration

   

0.123

 T1

2

0

2

 

 T2

68

46

22

 

 T3

37

19

18

 

 T4

6

2

4

 

lymphatic metastasis (N)

   

0.581

 N0

105

63

42

 

 N1

8

4

4

 

Stage

   

0.027

 I

14

12

2

 

 II

56

34

22

 

 III

31

15

16

 

 IV

12

6

6

 
Back to article page